Page 143 - CW E-Magazine (26-12-2023)
P. 143

Top Stories                                                                     Pharmaceuticals


 CLOSER TO CUSTOMERS  EVENT PARTICIPATION
 Pearl Polyurethane Systems establishes distribution   Clariant’s Healthcare business showcases key

 hub in Thane, Maharashtra  offerings at CPHI India


 Dubai-based PU system house,   of tailormade solutions and technical   Swiss  speciality  chemicals  fi rm,
 Pearl Polyurethane Systems, has   support not available elsewhere,” he   Clariant, announced that its Healthcare
 announced the setting  up of a distri-  added.  business registered its maiden presence
 bution hub in  Thane, near Mumbai,   at the  leading pharma industry  trade
 to better serve customers across the   The establishment of the new distri-  exhibition, CPHI  India 2023, held in
 Indian subcontinent.  bution  concept  is led  by Mr. Suman   Noida recently.
 Bandi, Pearl’s Business Development
 The company, a leading provider   Manager. “India aims to reach net zero   Clariant’s  Healthcare  business
 of polyurethane (PU)  insulation solu-  emissions by 2070 and meet  50 per   boasts of a strong portfolio of exci-
 tions and other PU-based applications,   cent of its electricity requirements from   pients and active pharmaceutical ingre-
 said the distribution hub, complete with  and customising Pearl’s  PU-based  renewable  energy sources by 2030.   dients (APIs),  backed by operational
 locally stored goods, will ensure short  applications to suit local conditions.”  This is a hugely signifi cant moment for   excellence  and years of experience  in
 lead times and provide vastly improved   the global fi ght against climate change   regulatory affairs. The business is po-
 services to Pearl’s customers in India.  “As an independent  system house  and gives Pearl an exciting opportunity   sitioned  as a ‘one-stop shop solution’
 chain,  we are actively  leveraging  our  to offer more sustainable PU insulation   of excipients  from  standard  to  highly
 Commenting  on the new hub’s  strengths of agility and customer-  systems and engage policymakers with-  purifi ed grades for application-specifi c
 launch, Mr. Martin Kruczinna, CEO of  centricity  to better serve our  global  in the country and help India achieve its   formulation  fl exibility  and  functional
 Pearl Polyurethane Systems  said, “As  clientele. This is all part of our strategic  sustainability goals,” he observed.  excipients to solve active pharmaceuti-
 we react  to the increased  number of  PearlX2 growth strategy, which will   cal ingredient (API)  delivery & bio-  Mr.  Vaios Barlas, Global  Head of
 new client enquiries from this growing  see  more  offi ce  locations  and  distri-  Pearl offers  a wide range of poly-  availability challenges.  Healthcare, at Clariant, commented,
 territory, our local team on the ground  bution hubs opening in key international  urethane formulations and prepolymers   “For Clariant, India represents a dyna-
 is well-positioned to provide world-  markets over the coming years, as more  for the production of high-performance   Among the key products showcased   mically growing market for functional
 class  solutions to  India-based clients  clients turn to Pearl for the unique type  polyurethane foams and elastomers.  at the show were the following two   excipients  of high  purity  beyond  just
 UPL recognised as fi rst agrochemical fi rm in Dow   offerings from the company’s Bontha-  pharmacopeia compliance with  an
                                                                          enormous potential into parenteral
       pally site in Telangana:
 Jones sustainability indices    Vitipure Meglumine LEX: a low-endo-     applications.
          toxin and microbial-load  grade  of
          meglumine. It is used as a counte-                                 Indian customers prefer excipient
 UPL Ltd. has announced its inclusion  UPL’s performance in the S&P Global  initiatives. Mr. Jai Shroff, Chairman and   rion  in  contrast  media  sector, as a   via a patented process to minimise  suppliers with stringent GMP  track
 in the Dow Jones Sustainability World and  2023 Corporate Sustainability  Assess-  Group CEO of UPL Group, said, “This   buffering agent/alkaliser  and solu-  residual impurities  in the product,  records and local manufacturing  for
 Emerging Markets Indices (DJSI).  The  ment. The DJSI, renowned for evaluating  milestone underlines our mission to   biliser for mild acidic APIs.  which makes it colourless, doorless,  shorter lead times. This was also evi-
 company reported that the recognition  Environment,  Social,  and  Governance  ‘Reimagining Sustainability’ and our     VitiPure Superior: a high-purity   with low microbial  load  and im-  dent from the very strong business
 marks an achievement for the company,  (ESG) practices, acknowledges the top  ongoing journey towards a better future   brand  that  offers  purifi ed  products   proves the stability of APIs.  connects we established at this event.”
 being the fi rst agrochemical fi rm to attain  10% of major global companies by in-  for our customers, our partners, our
 this status. The inclusion is attributed to  dustry for their sustainable development  employees, and the planet.”  AIDING TARGETED THERAPY

 RECOGNITION  Piramal Pharma arm opens expanded ADC facility
 Dhanuka Group Chairman conferred ‘Honorary Doctorate’  in Scotland


 In  recognition  of  his  exceptional   The Executive  Council of  Amity  professionalism in his continuous quest   Piramal  Pharma Solutions  (PPS),  a  Scotland, UK. PPS is a leading player in  city by approximately 70-80%, enabling
 service to the Indian farming community,  University had recommended  confe-  for making India’s agriculture  vibrant   Contract Development and Manufactur-  ADC development and manufacturing,  scale-up of commercial ADC manufac-
 Mr. Ram Gopal  Agarwal, Chairman,  rring the honour to the Dhanuka Group  as well as for making farming a dig-  ing  Organization (CDMO)  and  part  of  with hundreds of payloads developed  turing batches. The expansion, which has
 Dhanuka Group, has been bestowed a  Chairman considering his “deep com-  nifi ed profession with increased liveli-  Piramal Pharma, recently opened its ex-  and more than a thousand ADC batches  been completed for commercialisation
 Honorary  Doctorate (Honoris Causa)  mitment, strong  conviction, philan-  hood and heightened  social status,” a   panded antibody-drug conjugate (ADC)  manufactured.  The company said the  within this fi scal year, features two new
 by Amity University, NOIDA.   thropic engagement, and high degree of  press release from the Group said.  manufacturing facility in Grangemouth,  expansion further enhances the site’s capa-  ADC  manufacturing  suites  specifi cally


 142  Chemical Weekly  December 26, 2023  Chemical Weekly  December 26, 2023                           143


                                      Contents    Index to Advertisers    Index to Products Advertised
   138   139   140   141   142   143   144   145   146   147   148